Diosgenin ameliorates gestational diabetes through inhibition of sterol regulatory element-binding protein-1

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 1460-1465

  Hua, Shaofang ^a   Li, Yueqin ^a   Su, Lijun ^a   Liu, Xiajun ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Diosgenin; Gestational diabetes; Lipid profile; Oxidative stress; SREBP 1

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE 1; CATALASE; CHOLESTEROL; DIOSGENIN; FATTY ACID SYNTHASE; GLUCOSE; GLUTATHIONE; INSULIN; LOW DENSITY LIPOPROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; SREBF1 PROTEIN, MOUSE; STEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG PROTEIN BINDING; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; LIVER HOMOGENATE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; DIABETES, GESTATIONAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PREGNANCY; TRANSGENIC MOUSE;

ANIMALS; DIABETES, GESTATIONAL; DIOSGENIN; FEMALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXIDATIVE STRESS; PREGNANCY; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROLS;

EID: 85000894019     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.10.049     Document Type: Article

References (34)

1. [1] Coustan, D.R., Gestational diabetes mellitus. Clin. Chem. 59:9 (2013), 1310–1321.
2. [2] Gilmartin, A.B., Ural, S.H., Repke, J.T., Gestational diabetes mellitus. Rev. Obstet. Gynecol. 1:3 (2008), 129–134.
3. [3] Association, A.D., Gestational diabetes mellitus. Diabetes Care 27:Suppl. 1 (2004), S88–90.
4. [4] Gardosi, J., Francis, A., A customized standard to assess fetal growth in a US population. Am. J. Obstet. Gynecol. 201:1 (2009), 25.e1–25.e7.
5. [5] Tutino, G.E., Tam, W.H., Yang, X., Chan, J.C., Lao, T.T., Ma, R.C., Diabetes and pregnancy: perspectives from Asia. Diabetic Med.: J. Br. Diabetic Assoc. 31:3 (2014), 302–318.
6. [6] Fuller, S., Stephens, J.M., Diosgenin, 4-hydroxyisoleucine and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome. Adv. Nutr. (Bethesda, Md.) 6:2 (2015), 189–197.
7. [7] Gao, F., Shen, X.Z., Jiang, F., Wu, Y., Han, C., DNA-guided genome editing using the Natronobacterium gregoryi argonaute. Nat. Biotechnol. 34:7 (2016), 768–773.
8. [8] Wang, E., Wylie-Rosett, J., Review of selected Chinese herbal medicines in the treatment of type 2 diabetes. Diabetes Educ. 34:4 (2008), 645–654.
9. [9] Das, S., Dey, K.K., Dey, G., Pal, I., Majumder, A., MaitiChoudhury, S., kundu, S.C., Mandal, M., Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One, 7(10), 2012, e46641.
10. [10] Kalailingam, P., Kannaian, B., Tamilmani, E., Kaliaperumal, R., Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats. Phytomed.: Int. J. Phytother. Phytopharm. 21:10 (2014), 1154–1161.
11. [11] Pari, L., Monisha, P., Mohamed Jalaludeen, A., Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats. Eur. J. Pharmacol. 691:1–3 (2012), 143–150.
12. [12] Yamada, T., Hoshino, M., Hayakawa, T., Ohhara, H., Yamada, H., Nakazawa, T., Inagaki, T., Iida, M., Ogasawara, T., Uchida, A., Hasegawa, C., Murasaki, G., Miyaji, M., Hirata, A., Takeuchi, T., Dietary diosgenin attenuates subacute intestinal inflammation associated with indomethacin in rats. Am. J. Physiol. 273:2 Pt. 1 (1997), G355–G364.
13. [13] Hirai, S., Uemura, T., Mizoguchi, N., Lee, J.Y., Taketani, K., Nakano, Y., Hoshino, S., Tsuge, N., Narukami, T., Yu, R., Takahashi, N., Kawada, T., Diosgenin attenuates inflammatory changes in the interaction between adipocytes and macrophages. Mol. Nutr. Food Res. 54:6 (2010), 797–804.
14. [14] Kaufmann, R.C., Amankwah, K.S., Dunaway, G., Maroun, L., Arbuthnot, J., Roddick, J.W. Jr., An animal model of gestational diabetes. Am. J. Obstet. Gynecol. 141:5 (1981), 479–482.
15. [15] Ishizuka, T., Klepcyk, P., Liu, S., Panko, L., Liu, S., Gibbs, E.M., Friedman, J.E., Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes 48:5 (1999), 1061–1069.
16. [16] Lambin, S., van Bree, R., Caluwaerts, S., Vercruysse, L., Vergote, I., Verhaeghe, J., Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype. Am. J. Physiol. Endocrinol. Metab. 292:1 (2007), E262–E271.
17. [17] Yamashita, H., Shao, J., Ishizuka, T., Klepcyk, P.J., Muhlenkamp, P., Qiao, L., Hoggard, N., Friedman, J.E., Leptin administration prevents spontaneous gestational diabetes in heterozygous Lepr(db/+) mice: effects on placental leptin and fetal growth. Endocrinology 142:7 (2001), 2888–2897.
18. [18] Lawrence, S., Warshaw, J., Nielsen, H.C., Delayed lung maturation in the macrosomic offspring of genetically determined diabetic (db/+) mice. Pediatr. Res. 25:2 (1989), 173–179.
19. [19] Grunz-Borgmann, E., Mossine, V., Fritsche, K., Parrish, A.R., Ashwagandha attenuates TNF-alpha- and LPS-induced NF-kappaB activation and CCL2 and CCL5 gene expression in NRK-52E cells. BMC Complement. Altern. Med., 15, 2015, 434.
20. [20] Yao, L., Wan, J., Li, H., Ding, J., Wang, Y., Wang, X., Li, M., Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. Reprod. Biol. Endocrinol.: RB&E, 13, 2015, 118.
21. [21] Roghani-Dehkordi, F., Roghani, M., Baluchnejadmojarad, T., Diosgenin mitigates streptozotocin diabetes-induced vascular dysfunction of the rat aorta: the involved mechanisms. J. Cardiovasc. Pharmacol. 66:6 (2015), 584–592.
22. [22] Naidu, P.B., Ponmurugan, P., Begum, M.S., Mohan, K., Meriga, B., RavindarNaik, R., Saravanan, G., Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats. J. Sci. Food Agric. 95:15 (2015), 3177–3182.
23. [23] Hao, S., Xu, R., Li, D., Zhu, Z., Wang, T., Liu, K., Attenuation of streptozotocin-induced lipid profile anomalies in the heart, brain, and mRNA expression of HMG-CoA reductase by diosgenin in rats. Cell Biochem. Biophys. 72:3 (2015), 741–749.
24. [24] Chen, Y., Tang, Y.M., Yu, S.L., Han, Y.W., Kou, J.P., Liu, B.L., Yu, B.Y., Advances in the pharmacological activities and mechanisms of diosgenin. Chin. J. Nat. Med. 13:8 (2015), 578–587.
25. [25] Sato, K., Fujita, S., Iemitsu, M., Acute administration of diosgenin or dioscorea improves hyperglycemia with increases muscular steroidogenesis in STZ-induced type 1 diabetic rats. J. Steroid Biochem. Mol. Biol. 143 (2014), 152–159.
26. [26] Uemura, T., Goto, T., Kang, M.S., Mizoguchi, N., Hirai, S., Lee, J.Y., Nakano, Y., Shono, J., Hoshino, S., Taketani, K., Tsuge, N., Narukami, T., Makishima, M., Takahashi, N., Kawada, T., Diosgenin, the main aglycon of fenugreek, inhibits LXRalpha activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J. Nutr. 141:1 (2011), 17–23.
27. [27] Azimi, P., Ghiasvand, R., Feizi, A., Hariri, M., Abbasi, B., Effects of cinnamon, cardamom, saffron, and ginger consumption on markers of glycemic control, lipid profile, oxidative stress, and inflammation in type 2 diabetes patients. Rev. Diabetic Stud.: RDS 11:3–4 (2014), 258–266.
28. [28] Siewert, S., Gonzalez, I.I., Lucero, R.O., Ojeda, M.S., Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: a study in San Luis Argentina. J. Diabetes Investig. 6:1 (2015), 67–77.
29. [29] Knight, B.A., Shields, B.M., Hattersley, A.T., Vaidya, B., Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters. Eur. J. Endocrinol./Eur. Fed. Endocr. Soc. 174:1 (2016), 51–57.
30. [30] Jin, W.Y., Lin, S.L., Hou, R.L., Chen, X.Y., Han, T., Jin, Y., Tang, L., Zhu, Z.W., Zhao, Z.Y., Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth, 16(1), 2016, 60.
31. [31] Goldstein, J.L., DeBose-Boyd, R.A., Brown, M.S., Protein sensors for membrane sterols. Cell 124:1 (2006), 35–46.
32. [32] Li, J., Ding, L., Song, B., Xiao, X., Qi, M., Yang, Q., Yang, Q., Tang, X., Wang, Z., Yang, L., Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway. Eur. J. Pharmacol. 770 (2016), 99–109.
33. [33] Taskinen, M.R., Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46:6 (2003), 733–749.
34. [34] Moriwaki, S., Murakami, H., Takahashi, N., Uemura, T., Taketani, K., Hoshino, S., Tsuge, N., Narukami, T., Goto, T., Kawada, T., Yamogenin in fenugreek inhibits lipid accumulation through the suppression of gene expression in fatty acid synthesis in hepatocytes. Biosci. Biotechnol. Biochem. 78:7 (2014), 1231–1236.